Campigotto, M.; Priotto, F.; Tonello, C.F.; Monica, F.; Crocè, S.L.
Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report. Reports 2025, 8, 37.
https://doi.org/10.3390/reports8020037
AMA Style
Campigotto M, Priotto F, Tonello CF, Monica F, Crocè SL.
Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report. Reports. 2025; 8(2):37.
https://doi.org/10.3390/reports8020037
Chicago/Turabian Style
Campigotto, Michele, Francesca Priotto, Cinzia Francesca Tonello, Fabio Monica, and Saveria Lory Crocè.
2025. "Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report" Reports 8, no. 2: 37.
https://doi.org/10.3390/reports8020037
APA Style
Campigotto, M., Priotto, F., Tonello, C. F., Monica, F., & Crocè, S. L.
(2025). Efficacy and Safety of Upadacitinib and Vedolizumab Combination for Refractory Orofacial Granulomatosis Associated with Panenteric Crohn’s Disease: A Case Report. Reports, 8(2), 37.
https://doi.org/10.3390/reports8020037